Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 31 October 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Higher raw material prices, increased research and development expenses for next-generation products, recognition of income from technology fees received and foreign exchange gains, and recognition of impairment losses arising from the decline in the profitability of assets, among other factors.
Impairment loss arising from the decline in the profitability of assets (amount not stated)
| Item | Details |
|---|---|
| Net Sales | ¥38,800 million → ¥38,323 million（-1.2%） |
| Operating profit | ¥700 million → ¥306 million（-56.2%） |
| Ordinary income | ¥700 million → ¥728 million（+4.0%） |
| Profit attributable to owners of the parent | ¥480 million → ¥70 million（-85.4%） |
| Net income per share | 42.86 yen and sen → 6.26 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 31 October 2025 |
| Previous-period results | Consolidated: net sales of ¥34,974 million, operating income of ¥438 million, ordinary income of ¥419 million, profit attributable to owners of the parent of ¥178 million, and earnings per share of ¥15.90. Individual: net sales of ¥34,922 million, operating loss of ¥64 million, ordinary income of ¥158 million, net loss of ¥121 million, and earnings per share of negative ¥10.87. |
| Reason for the revision | Higher raw material prices, increased research and development expenses for next-generation products, recognition of income from technology fees received and foreign exchange gains, and recognition of impairment losses arising from the decline in the profitability of assets, among other factors. |
| Details and amount of extraordinary loss | Impairment loss arising from the decline in the profitability of assets (amount not stated) |
| Consolidated / non-consolidated | Consolidated / non-consolidated (standalone) |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Although net sales were broadly in line with the plan, operating income was below the forecast due to higher raw material prices and increased research and development expenses for next-generation products. Income from technology fees received and foreign exchange gains supported ordinary income, while profit attributable to owners of the parent was below the forecast due to impairment losses arising from the decline in the profitability of assets and other factors. The differences in individual actual results were attributable to largely the same factors.